APA

Kruithof E., Van den Bosch F., Baeten D., Herssens A., De Keyser F., Mielants H. & Veys E. M. (20020308). Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. : Annals of the rheumatic diseases.

Chicago

Kruithof E, Van den Bosch F, Baeten D, Herssens A, De Keyser F, Mielants H and Veys E M. 20020308. Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. : Annals of the rheumatic diseases.

Harvard

Kruithof E., Van den Bosch F., Baeten D., Herssens A., De Keyser F., Mielants H. and Veys E. M. (20020308). Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. : Annals of the rheumatic diseases.

MLA

Kruithof E, Van den Bosch F, Baeten D, Herssens A, De Keyser F, Mielants H and Veys E M. Repeated infusions of infliximab, a chimeric anti-TNFalpha monoclonal antibody, in patients with active spondyloarthropathy: one year follow up. : Annals of the rheumatic diseases. 20020308.